Gregoire Boulouis1, Andreas Charidimou2, Marco Pasi2, Duangnapa Roongpiboonsopit3, Li Xiong2, Eitan Auriel2, Ellis S van Etten4, Sergi Martinez-Ramirez2, Alison Ayres2, Anastasia Vashkevich2, Kristin M Schwab2, Jonathan Rosand5, Joshua N Goldstein5, M Edip Gurol2, Steven M Greenberg2, Anand Viswanathan2. 1. Hemorrhagic Stroke Research Program, Department of Neurology, Massachusetts General Hospital Stroke Research Center, Harvard Medical School, Boston, MA, USA. Electronic address: g.boulouis@ch-sainte-anne.fr. 2. Hemorrhagic Stroke Research Program, Department of Neurology, Massachusetts General Hospital Stroke Research Center, Harvard Medical School, Boston, MA, USA. 3. Hemorrhagic Stroke Research Program, Department of Neurology, Massachusetts General Hospital Stroke Research Center, Harvard Medical School, Boston, MA, USA; Department of Medicine, Faculty of Medicine, Naresuan University, Phitsanulok, Thailand. 4. Hemorrhagic Stroke Research Program, Department of Neurology, Massachusetts General Hospital Stroke Research Center, Harvard Medical School, Boston, MA, USA; Department of Neurology, Leiden University Medical Center, Leiden, The Netherlands. 5. Hemorrhagic Stroke Research Program, Department of Neurology, Massachusetts General Hospital Stroke Research Center, Harvard Medical School, Boston, MA, USA; Division of Neurocritical Care and Emergency Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Abstract
INTRODUCTION: An MRI-based score of total small vessel disease burden (CAA-SVD-Score) in cerebral amyloid angiopathy (CAA) has been demonstrated to correlate with severity of pathologic changes. Evidence suggests that CAA-related intracerebral hemorrhage (ICH) recurrence risk is associated with specific disease imaging manifestations rather than overall severity. We compared the correlation between the CAA-SVD-Score with the risk of recurrent CAA-related lobar ICH versus the predictive role of each of its components. METHODS: Consecutive patients with CAA-related ICH from a single-center prospective cohort were analyzed. Radiological markers of CAA related SVD damage were quantified and categorized according to the CAA-SVD-Score (0-6 points). Subjects were followed prospectively for recurrent symptomatic ICH. Adjusted Cox proportional hazards models were used to investigate associations between the CAA-SVD-Score as well as each of the individual MRI signatures of CAA and the risk of recurrent ICH. RESULTS: In 229 CAA patients with ICH, a total of 56 recurrent ICH events occurred during a median follow-up of 2.8years [IQR 0.9-5.4years, 781 person-years). Higher CAA-SVD-Score (HR=1.26 per additional point, 95%CI [1.04-1.52], p=0.015) and older age were independently associated with higher ICH recurrence risk. Analysis of individual markers of CAA showed that CAA-SVD-Score findings were due to the independent effect of disseminated superficial siderosis (HR for disseminated cSS vs none: 2.89, 95%CI [1.47-5.5], p=0.002) and high degree of perivascular spaces enlargement (RR=3.50-95%CI [1.04-21], p=0.042). CONCLUSION: In lobar CAA-ICH patients, higher CAA-SVD-Score does predict recurrent ICH. Amongst individual elements of the score, superficial siderosis and dilated perivascular spaces are the only markers independently associated with ICH recurrence, contributing to the evidence for distinct CAA phenotypes singled out by neuro-imaging manifestations.
INTRODUCTION: An MRI-based score of total small vessel disease burden (CAA-SVD-Score) in cerebral amyloid angiopathy (CAA) has been demonstrated to correlate with severity of pathologic changes. Evidence suggests that CAA-related intracerebral hemorrhage (ICH) recurrence risk is associated with specific disease imaging manifestations rather than overall severity. We compared the correlation between the CAA-SVD-Score with the risk of recurrent CAA-related lobar ICH versus the predictive role of each of its components. METHODS: Consecutive patients with CAA-related ICH from a single-center prospective cohort were analyzed. Radiological markers of CAA related SVD damage were quantified and categorized according to the CAA-SVD-Score (0-6 points). Subjects were followed prospectively for recurrent symptomatic ICH. Adjusted Cox proportional hazards models were used to investigate associations between the CAA-SVD-Score as well as each of the individual MRI signatures of CAA and the risk of recurrent ICH. RESULTS: In 229 CAA patients with ICH, a total of 56 recurrent ICH events occurred during a median follow-up of 2.8years [IQR 0.9-5.4years, 781 person-years). Higher CAA-SVD-Score (HR=1.26 per additional point, 95%CI [1.04-1.52], p=0.015) and older age were independently associated with higher ICH recurrence risk. Analysis of individual markers of CAA showed that CAA-SVD-Score findings were due to the independent effect of disseminated superficial siderosis (HR for disseminated cSS vs none: 2.89, 95%CI [1.47-5.5], p=0.002) and high degree of perivascular spaces enlargement (RR=3.50-95%CI [1.04-21], p=0.042). CONCLUSION: In lobar CAA-ICHpatients, higher CAA-SVD-Score does predict recurrent ICH. Amongst individual elements of the score, superficial siderosis and dilated perivascular spaces are the only markers independently associated with ICH recurrence, contributing to the evidence for distinct CAA phenotypes singled out by neuro-imaging manifestations.
Authors: Andreas Charidimou; Gregoire Boulouis; M Edip Gurol; Cenk Ayata; Brian J Bacskai; Matthew P Frosch; Anand Viswanathan; Steven M Greenberg Journal: Brain Date: 2017-07-01 Impact factor: 13.501
Authors: Jennifer Linn; Frank A Wollenweber; Nina Lummel; Katja Bochmann; Thomas Pfefferkorn; Andreas Gschwendtner; Hartmut Bruckmann; Martin Dichgans; Christian Opherk Journal: J Neurol Date: 2012-07-22 Impact factor: 4.849
Authors: Alessandro Biffi; Christopher D Anderson; Thomas W K Battey; Alison M Ayres; Steven M Greenberg; Anand Viswanathan; Jonathan Rosand Journal: JAMA Date: 2015-09-01 Impact factor: 56.272
Authors: Andreas Charidimou; Gregoire Boulouis; Kellen Haley; Eitan Auriel; Ellis S van Etten; Panagiotis Fotiadis; Yael Reijmer; Alison Ayres; Anastasia Vashkevich; Zora Y Dipucchio; Kristin M Schwab; Sergi Martinez-Ramirez; Jonathan Rosand; Anand Viswanathan; Steven M Greenberg; M Edip Gurol Journal: Neurology Date: 2016-01-08 Impact factor: 9.910
Authors: Andreas Charidimou; Sergi Martinez-Ramirez; Yael D Reijmer; Jamary Oliveira-Filho; Arne Lauer; Duangnapa Roongpiboonsopit; Matthew Frosch; Anastasia Vashkevich; Alison Ayres; Jonathan Rosand; Mahmut Edip Gurol; Steven M Greenberg; Anand Viswanathan Journal: JAMA Neurol Date: 2016-08-01 Impact factor: 18.302
Authors: Susanne J van Veluw; Geert Jan Biessels; Willem H Bouvy; Wim Gm Spliet; Jaco Jm Zwanenburg; Peter R Luijten; Eric A Macklin; Annemieke Jm Rozemuller; M Edip Gurol; Steven M Greenberg; Anand Viswanathan; Sergi Martinez-Ramirez Journal: J Cereb Blood Flow Metab Date: 2015-12-07 Impact factor: 6.200
Authors: Juan Pablo Castello; Marco Pasi; Jessica R Abramson; Axana Rodriguez-Torres; Sandro Marini; Stacie Demel; Lee Gilkerson; Patryk Kubiszewski; Andreas Charidimou; Christina Kourkoulis; Zora DiPucchio; Kristin Schwab; M Edip Gurol; Anand Viswanathan; Christopher D Anderson; Carl D Langefeld; Matthew L Flaherty; Amytis Towfighi; Steven M Greenberg; Daniel Woo; Jonathan Rosand; Alessandro Biffi Journal: Neurology Date: 2021-04-21 Impact factor: 9.910
Authors: Patryk Kubiszewski; Lansing Sugita; Christina Kourkoulis; Zora DiPucchio; Kristin Schwab; Christopher D Anderson; M Edip Gurol; Steven M Greenberg; Anand Viswanathan; Jonathan Rosand; Alessandro Biffi Journal: JAMA Neurol Date: 2020-08-31 Impact factor: 18.302
Authors: Joanna M Wardlaw; Helene Benveniste; Maiken Nedergaard; Berislav V Zlokovic; Humberto Mestre; Hedok Lee; Fergus N Doubal; Rosalind Brown; Joel Ramirez; Bradley J MacIntosh; Allen Tannenbaum; Lucia Ballerini; Ravi L Rungta; Davide Boido; Melanie Sweeney; Axel Montagne; Serge Charpak; Anne Joutel; Kenneth J Smith; Sandra E Black Journal: Nat Rev Neurol Date: 2020-02-24 Impact factor: 42.937